Amaran Biotech wins best CDMO award for automated aseptic filling at Taiwan Biopharma Excellence Awards 2025
Amaran Biotech, a leading Contract Development and Manufacturing Organization (CDMO), was recognized as the “Best CDMO in Automated Aseptic Filling” at the Taiwan Biopharma Excellence Awards 2025. The prestigious event, held on March 26 at the Hilton Taipei Sinban, celebrated the company’s achievements in advancing robotic aseptic filling technology for biopharmaceutical production.
Recognition for innovation in aseptic drug manufacturing
The Taiwan Biopharma Excellence Awards, organized by international consulting firm IMAPAC, honors organizations that drive innovation in biomanufacturing. The awards highlight breakthroughs that contribute to faster, more cost-effective, and high-quality drug production, benefiting the global pharmaceutical industry.
The event was held alongside IMAPAC’s 12th Biologics World Taiwan 2025 and 4th Stem Cells & Regenerative Medicine Asia 2025, bringing together nearly 300 industry leaders from biopharmaceutical, vaccine manufacturing, and biologics companies.
Automated aseptic filling: a game changer for biopharma
Amaran Biotech revolutionized Taiwan’s biopharmaceutical industry by introducing the country’s first fully automated aseptic filling line in 2022. The company utilizes the Cytiva (Vanrx) SA25 robotic aseptic filling system, significantly reducing human intervention and enhancing drug safety and sterility.
Key benefits of this system include:
-
99.99% filling accuracy for biologics, including protein therapeutics and antibody drugs
-
Low-waste, high-quality solutions for high-value drug manufacturing
-
Support for multiple container types, including vials, pre-filled syringes, and cartridges
Overcoming challenges to lead in automated biopharma solutions
In her acceptance speech, Dr. Tessie Che, Chairperson and General Manager of Amaran Biotech, reflected on the challenges of launching the automated aseptic filling line during the COVID-19 pandemic.
“We are deeply honored to receive this prestigious recognition from IMAPAC. This award belongs to our entire team!”
“When we decided to build our automated aseptic filling line in 2020, the pandemic presented major hurdles—international engineers couldn’t travel to Taiwan for installation. Through remote collaboration, we successfully implemented the system while ensuring compliance with FDA, EMA, ICH, PIC/S, and ISPE regulatory standards.”
Future outlook: AI-driven CDMO solutions
Looking ahead, Amaran Biotech aims to further integrate AI technology into its CDMO services to enhance production efficiency and precision. The company remains committed to customized, high-tech manufacturing solutions, reinforcing its position as a global leader in pharmaceutical innovation.
